PubRank

S Efendić

Author PubWeight™ 106.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 1987 2.09
2 Effect of adrenergic blocking agents on insulin response to glucose infusion in man. Acta Endocrinol (Copenh) 1972 1.76
3 Glucose and tolbutamide induce apoptosis in pancreatic beta-cells. A process dependent on intracellular Ca2+ concentration. J Biol Chem 1998 1.57
4 Cellular localization of somatostatin in endocrine-like cells and neurons of the rat with special references to the A1-cells of the pancreatic islets and to the hypothalamus. Acta Endocrinol Suppl (Copenh) 1975 1.34
5 Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release. Eur J Biochem 1988 1.34
6 Enkephalin- and somatostatin-like immunoreactivities in human adrenal medulla and pheochromocytoma. Proc Natl Acad Sci U S A 1979 1.26
7 Insulin release, insulin sensitivity, and glucose intolerance. Proc Natl Acad Sci U S A 1980 1.19
8 Diabetes in pregnancy: effects on the foetal and newborn rat with particular regard to body weight, serum insulin concentration and pancreatic contents of insulin, glucagon and somatostatin. Acta Endocrinol (Copenh) 1980 1.15
9 Aspects of the pathogenesis of type 2 diabetes. Endocr Rev 1984 1.14
10 Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans. J Clin Invest 1977 1.13
11 Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki rats. Diabetes 1997 1.13
12 Normalization by insulin treatment of low mitochondrial glycerol phosphate dehydrogenase and pyruvate carboxylase in pancreatic islets of the GK rat. Diabetes 1996 1.10
13 Interaction of a newly isolated intestinal polypeptide (PHI) with glucose and arginine to effect the secretion of insulin and glucagon. Life Sci 1980 1.04
14 Glucose and fructose 6-phosphate cycle in humans. Am J Physiol 1986 1.03
15 Increased activity of the glucose cycle in the liver: early characteristic of type 2 diabetes. Proc Natl Acad Sci U S A 1985 1.00
16 Somatostatin--both hormone and neurotransmitter? Diabetologia 1978 0.97
17 Evidence for the presence of glucose cycling in pancreatic islets of the ob/ob mouse. J Biol Chem 1989 0.96
18 Effect of composition of mixed meals--low- versus high-carbohydrate content--on insulin, glucagon, and somatostatin release in healthy humans and in patients with NIDDM. Diabetes Care 1986 0.96
19 Protein kinase C activity affects glucose-induced oscillations in cytoplasmic free Ca2+ in the pancreatic B-cell. FEBS Lett 1992 0.96
20 Testing of the assumptions made in estimating the extent of futile cycling. Am J Physiol 1989 0.95
21 Circulatory effects of somatostatin in anaesthetized dogs. Acta Chir Scand 1979 0.94
22 Insulin resistance and decreased insulin response to glucose in lean type 2 diabetics. Proc Natl Acad Sci U S A 1982 0.93
23 Previous exposure to glucose enhances somatostatin secretion from the isolated perfused rat pancreas. Diabetologia 1981 0.93
24 Catecholamines and metabolism of human adipose tissue. II. Effect of isoprophylnoradrenaline and adrenergic blocking agents on lipolysis in human omental adipose tissue in vitro. Acta Med Scand 1970 0.92
25 Treatment of bleeding oesophageal varices with somatostatin. Acta Chir Scand 1979 0.92
26 Glucose cycling in islets from healthy and diabetic rats. Diabetes 1990 0.92
27 Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM. Diabetes Care 1994 0.91
28 Effect of glucose/sulfonylurea interaction on release of insulin, glucagon, and somatostatin from isolated perfused rat pancreas. Proc Natl Acad Sci U S A 1979 0.91
29 Isolation and characterization of a 60-residue intestinal peptide structurally related to the pancreatic secretory type of trypsin inhibitor: influence on insulin secretion. Proc Natl Acad Sci U S A 1989 0.91
30 Adenylyl cyclase isoform expression in non-diabetic and diabetic Goto-Kakizaki (GK) rat pancreas. Evidence for distinct overexpression of type-8 adenylyl cyclase in diabetic GK rat islets. Histochem Cell Biol 2000 0.90
31 Minimal increases in glucagon levels enhance glucose production in man with partial hypoinsulinemia. Diabetes 1983 0.90
32 Effects of somatostatin on gastrointestinal propagation and absorption of oral glucose in man. Digestion 1981 0.90
33 Dissociation between changes in cytoplasmic free Ca2+ concentration and insulin secretion as evidenced from measurements in mouse single pancreatic islets. Proc Natl Acad Sci U S A 1995 0.89
34 Effect of somatostatin on intestinal motility. Acta Radiol Diagn (Stockh) 1978 0.88
35 Potentiation of glucose-induced insulin release by glucose in the isolated pancreas of fed and fasted rats. Diabetes 1976 0.87
36 Imidazoline compounds stimulate insulin release by inhibition of K(ATP) channels and interaction with the exocytotic machinery. Diabetes 1996 0.86
37 Sulphonylurea (glubenclamide) enhances somatostatin and inhibits glucagon release induced by arginine. Acta Physiol Scand 1980 0.86
38 Genetic regulation of the kinetics of glucose-induced insulin release in man. Studies in families with diabetic and non-diabetic probands. Clin Genet 1985 0.86
39 Effect of 24-hour somatostatin infusion on glucose homeostasis and on the levels of somatomedin A and pancreatic and thyroid hormones in man. Acta Med Scand 1979 0.86
40 Increased glucose turnover and glucose cycling in acromegalic patients with normal glucose tolerance. Diabetologia 1986 0.86
41 Effect of phentolamine and preperfusion with glucose on insulin release from the isolated perfused pancreas from fasted and fed rats. Diabetologia 1975 0.86
42 Cellular localization of somatostatin. Metabolism 1978 0.86
43 Measurements of cytoplasmic free Ca2+ concentration in human pancreatic islets and insulinoma cells. FEBS Lett 1991 0.85
44 Retinal microangiopathy and pigment epithelial lesions in subjects with normal, borderline, and decreased oral glucose tolerance. Br J Ophthalmol 1985 0.85
45 Mutations in the promoter of adenylyl cyclase (AC)-III gene, overexpression of AC-III mRNA, and enhanced cAMP generation in islets from the spontaneously diabetic GK rat model of type 2 diabetes. Diabetes 1998 0.84
46 Circulatory effects of somatostatin in anesthetized man. Acta Chir Scand 1979 0.84
47 Pancreastatin inhibits insulin secretion and stimulates glucagon secretion in mice. Diabetes 1988 0.84
48 Effects of glucose and arginine on the release of immunoreactive somatostatin from the isolated perfused rat pancreas. FEBS Lett 1978 0.84
49 Insulin sensitivity and glucose-induced insulin response changes during adolescence. Acta Paediatr Scand 1990 0.84
50 Studies on the mechanisms of somatostatin action on insulin release. IV. effect of somatostatin on cyclic AMP levels and phosphodiesterase activity in isolated rat pancreatic islets. Acta Endocrinol (Copenh) 1977 0.84
51 Stimulatory effect in vitro of prostaglandin E 1 on noradrenaline-induced lipolysis in subcutaneous adipose tissue from hypothyroid subjects. Acta Med Scand 1971 0.83
52 Release of somatostatin into the antral lumen of cats. Metabolism 1978 0.83
53 Counterregulation of insulin-induced hypoglycaemia in primary hypothyroidism. Acta Endocrinol (Copenh) 1986 0.83
54 Effects of Ca ++ on lipolysis in human omental adipose tissue in vitro. Horm Metab Res 1970 0.83
55 Neurohormonal regulation of the insulin stimulus-secretion coupling in pancreatic islets. Exp Clin Endocrinol Diabetes 2001 0.83
56 Antagonism between glucose and epinephrine regarding insulin secretion. A dose-response study in man. Acta Med Scand 1971 0.83
57 Low insulin response -- genetic aspects and implications. Horm Metab Res 1979 0.83
58 Catecholamines and metabolism of human adipose tissue. I. Comparison between in vitro effects of noradrenaline, adrenaline and theophylline on lipolysis in omental adipose tissue. Acta Med Scand 1969 0.82
59 Influence of the hypothyroid state on lipolysis in human adipose tissue in vitro. Hypothyroid state and lipolysis. Acta Med Scand 1971 0.82
60 Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas: evidence for a direct, non-paracrine effect. Diabetologia 1986 0.82
61 Effects of cholecystokinin, gastric inhibitory polypeptide, and secretin on insulin and glucagon secretion in rats. Endocrinology 1982 0.82
62 Effect of GIP on the secretion of insulin and somatostatin and the accumulation of cyclic AMP in vitro in the rat. Acta Endocrinol (Copenh) 1982 0.81
63 Increased amounts of a high molecular weight insulin-like growth factor II (IGF-II) peptide and IGF-II messenger ribonucleic acid in pancreatic islets of diabetic Goto-Kakizaki rats. Endocrinology 1996 0.81
64 Impaired coupling of glucose signal to the exocytotic machinery in diabetic GK rats: a defect ameliorated by cAMP. Diabetes 1996 0.81
65 Oral glucose tolerance test and insulin sensitivity in low insulin responders. Acta Endocrinol (Copenh) 1983 0.81
66 Catecholamines and metabolism of human adipose tissue. 3. Comparison between the regulation of lipolysis in omental and subcutaneous adipose tissue. Acta Med Scand 1970 0.81
67 Direct inhibition of the pancreatic beta-cell ATP-regulated potassium channel by alpha-ketoisocaproate. J Biol Chem 1998 0.81
68 Studies on the mechanism of somatostatin action on insulin release. III. Effect of somatostatin on arginine induced release of insulin and glucagon in man and perfused rat pancreas. Acta Endocrinol (Copenh) 1976 0.81
69 The empty sella syndrome--intrasellar cisternal herniation--in "normal" patients and in patients with communicating hydrocephalus and intracranial tumors. Neuroradiology 1978 0.80
70 The occurrence of somatostatin-like immunoreactivity in the vagal nerves. Acta Physiol Scand 1978 0.80
71 Glyburide decreases insulin requirement, increases beta-cell response to mixed meal, and does not affect insulin sensitivity: effects of short- and long-term combined treatment in secondary failure to sulfonylurea. Diabetes Care 1988 0.80
72 Effects of porcine intestinal heptacosapeptide and vasoactive intestinal polypeptide on insulin and glucagon secretion in rats. Endocrinology 1983 0.80
73 Signaling and sites of interaction for RX-871024 and sulfonylurea in the stimulation of insulin release. Am J Physiol 1998 0.80
74 Basal and meal-induced somatostatin-like immunoreactivity in healthy subjects and in IDDM and totally pancreatectomized patients. Effects of acute blood glucose normalization. Diabetes 1987 0.80
75 On the pathogenesis of maturity-onset diabetes. Diabetes Care 1981 0.80
76 Long term inhibitory effects of pancreastatin and diazepam binding inhibitor on pancreatic beta-cell deoxyribonucleic acid replication, polyamine content, and insulin secretion. Endocrinology 1991 0.80
77 Delayed Ca2+ response to glucose in diabetic GK rat. Biochem Biophys Res Commun 1997 0.79
78 Modulation by IBMX, fasting and experimental diabetes of glibenclamide-induced islet hormone release from the perfused rat pancreas. Diabete Metab 1983 0.79
79 Glucose turnover in hyperthyroid patients with normal glucose tolerance. J Clin Endocrinol Metab 1989 0.79
80 Insulin-stimulated glucose uptake is enhanced in sedentary and endurance-trained low insulin responders. Am J Physiol 1995 0.79
81 Effects of PHI on hormonal secretion from perfused rat pancreas. Am J Physiol 1983 0.79
82 Screening for insulin receptor gene DNA polymorphisms associated with glucose intolerance in a Scandinavian population. Diabetologia 1991 0.79
83 Hyperglycemia induced by somatostatin in normal subjects. Horm Metab Res 1976 0.79
84 RX871024 induces Ca2+ mobilization from thapsigargin-sensitive stores in mouse pancreatic beta-cells. Diabetes 1998 0.78
85 Studies on the mechanism of somatostatin action on insulin release in man. II. Comparison of the effects of somatostatin on insulin release induced by glucose, glucagon and tolbutamide. Acta Endocrinol (Copenh) 1976 0.78
86 Potentiation and inhibition of insulin release in man following priming with glucose and with arginine--effect of somatostatin. Acta Endocrinol (Copenh) 1979 0.78
87 DNA haplotype analysis suggests linkage disequilibrium in the human insulin receptor gene. Hum Genet 1991 0.78
88 Influence of prostaglandin E1 on lipolysis induced by noradrenaline, isopropylnoradrenaline, theophylline, and dibutyryl cAMP in human omental adipose tissue in vitro. Acta Med Scand 1970 0.78
89 Expression of glucose-6-phosphatase system genes in murine cortex and hypothalamus. Horm Metab Res 2006 0.78
90 Pituitary function in the empty sella syndrome. Neuroendocrinology 1981 0.78
91 Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action. J Clin Endocrinol Metab 1986 0.78
92 Responses of patients with insulinomas to stimulators and inhibitors of insulin release that have been linked with cyclic adenosine monophosphate. Diabetes 1979 0.78
93 Increased storage and secretion of islet amyloid polypeptide relative to insulin in the spontaneously diabetic GK rat. Pancreas 1996 0.78
94 Selective effect of some somatostatin analogs on glucagon as opposed to insulin release in rats in vivo. Metabolism 1980 0.78
95 Glucose-induced insulin response is reduced and proinsulin response increased in healthy siblings of type 1 diabetic patients. Diabet Med 1991 0.78
96 On the pathogenesis of maturity-onset diabetes mellitus. Acta Diabetol Lat 1979 0.78
97 Quantitative study on the potentiating effect of arginine on glucose-induced insulin response in healthy, prediabetic, and diabetic subjects. Diabetes 1974 0.78
98 Relative effects of somatostatin and two somatostatin analogues on the release of insulin, glucagon and growth hormone. FEBS Lett 1975 0.77
99 Treatment of bleeding esophageal varices with somatostatin. N Engl J Med 1978 0.77
100 Studies on low insulin responders. Glucose tolerance and insulin response to intravenous and oral glucose challenges in 226 normal subjects and 25 subjects with mild or chemical diabetes. Acta Endocrinol Suppl (Copenh) 1979 0.77
101 Both somatostatin and insulin responses to glucose are impaired in the perfused pancreas of the spontaneously noninsulin-dependent diabetic GK (Goto-Kakizaki) rats. Acta Physiol Scand 1993 0.77
102 Arachidonic acid signaling is involved in the mechanism of imidazoline-induced KATP channel-independent stimulation of insulin secretion. Cell Mol Life Sci 2007 0.77
103 The interaction of vasoactive intestinal polypeptide (VIP), glucose and arginine on the secretion of insulin, glucagon and somatostatin in the perfused rat pancreas. Diabetologia 1980 0.77
104 Efficacy of somatostatin in a patient with carcinoid syndrome. Lancet 1978 0.77
105 Modulation of experimental allergic encephalomyelitis by somatostatin. Ann N Y Acad Sci 1992 0.77
106 Alpha-adrenergic receptors in human omentum? Lancet 1969 0.77
107 Catecholamines and metabolism of human adipose tissue. IV. Influence of glucose on catecholamine induced lipolysis in human omental adipose tissue in vitro. Acta Med Scand 1970 0.77
108 Effects of PYY and PP on endocrine pancreas. Acta Physiol Scand 1983 0.77
109 A defective stimulus-secretion coupling rather than glucotoxicity mediates the impaired insulin secretion in the mildly diabetic F1 hybrids of GK-Wistar rats. Diabetes 1995 0.77
110 Studies on the mechanism of somatostatin action on insulin release in man. I. Effect of blockade of alpha-adrenergic receptors. Acta Endocrinol (Copenh) 1975 0.77
111 Evidence for an autosomal recessive gene regulating the persistence of the insulin response to glucose in man. Clin Genet 1982 0.77
112 A stimulating effect of glucose on somatostatin release is impaired in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1984 0.77
113 Some phylogenetical aspects on the occurrence of somatostatin in the gastro-entero pancreatic endocrine system. A histological and immunocytochemical study, combined with quantitative radioimmunological assays of tissue extracts. Arch Histol Jpn 1977 0.77
114 Loss of a priming effect of glucose on A and D cell secretion in perfused pancreases from alloxan-diabetic rats: role of insulin and alloxan. Diabetologia 1983 0.76
115 Dietary fiber decreases fasting blood glucose levels and plasma LDL concentration in noninsulin-dependent diabetes mellitus patients. Am J Clin Nutr 1988 0.76
116 Potentiation of glucose-induced insulin secretion in the perfused rat pancreas by porcine GIP (gastric inhibitory polypeptide), bovine GIP, and bovine GIP(1-39). Acta Physiol Scand 1986 0.76
117 Effect of blockade of the alpha-adrenergic receptors on insulin response to glucose infusion in prediabetic subjects. Acta Endocrinol (Copenh) 1973 0.76
118 Insulin, glucagon and somatostatin in the perfused rat pancreas and the effects of HB 699 (4-(2-(5-chloro-2-metoxy-benzamido)-ethyl)-benzoic acid). Acta Endocrinol (Copenh) 1981 0.76
119 Studies on the inhibitory effect of somatostatin on glucose induced insulin release in the isolated perfused rat pancreas. Acta Endocrinol (Copenh) 1975 0.76
120 Effects of short-term and prolonged infusions of somatostatin on endocrine pancreas, body weight and food intake in rats. Acta Physiol Scand 1980 0.76
121 Genetic and environmental determinants for lipoprotein concentrations in blood. Acta Med Scand 1985 0.76
122 Preoperative localization of aldosterone-producing adenomas. An analysis of the efficiency of different diagnostic procedures made from 11 cases and from a review of the literature. Acta Med Scand 1980 0.75
123 Stimulation by calcium and barium of somatostatin release. Evidence for lower sensitivity of D- vis-à-vis B- and A-cells. Acta Physiol Scand 1984 0.75
124 Reduced glycemic response to beet-fibre meal in non-insulin-dependent diabetics and its relation to plasma levels of pancreatic and gastrointestinal hormones. Diabetes Res 1986 0.75
125 Somatostatin. A classical hormone, a locally active polypeptide and a neurotransmitter. Ann Clin Res 1980 0.75
126 The immunohistochemical observation of somatostatin-like and avian pancreatic polypeptide-like immunoreactivity in certain cellular elements of diabetic lipodystrophic skin. Dermatologica 1985 0.75
127 Glibenclamide stimulates and glucose inhibits glucagon release induced by calcium deprivation. Diabetes 1984 0.75
128 Blood glucose and plasma glycerol response to epinephrine infusion in normal and prediabetic subjects. Acta Med Scand 1971 0.75
129 Significance of maternal corticosteroids in fetal adrenal development and organogenesis. Gen Comp Endocrinol 1968 0.75
130 Insulin glargine improves glycaemic control after coronary surgery in patients with diabetes or pre-diabetes. Scand Cardiovasc J 2008 0.75
131 The Staub-Traugott effect. Evidence for multifactorial regulation of a physiological function. Scand J Clin Lab Invest 1982 0.75
132 Evidence that a "memory' for glucose metabolism desensitizes A-cell responsiveness in the perfused pancreas of the rat. Acta Endocrinol (Copenh) 1985 0.75
133 Cardiovascular reflexes in short-term diabetics with normal physical working capacity. Scand J Clin Lab Invest 1980 0.75
134 The modulation of immunologic potential of splenocytes in induction of local GVHR by somatostatin. Ann N Y Acad Sci 1987 0.75
135 Catecholamines and metabolism of human adipose tissue. V. Studies on the incorporation of glucose-1-14C into lipids and the re-esterification of FFA by human omental tissue in vitro. Acta Med Scand 1970 0.75
136 The role of glucagon, catecholamines and cortisol in counterregulation of insulin-induced hypoglycemia in normal man. Acta Med Scand 1986 0.75
137 [Somatostatin, something more than a 3d pancreatic hormone]. Rev Clin Esp 1977 0.75
138 [Somatostatin, hormone of the pancreatic alpha 1 cells]. Med Pregl 1977 0.75
139 Glucose metabolism in the basal state and during a two-hour glucose infusion in low insulin responders and control subjects. Horm Metab Res 1982 0.75
140 Renin secretion in vitro from rat kidney cortex slices. 1. Influence of glucose on renin secretion. Acta Endocrinol (Copenh) 1969 0.75
141 Studies on the mechanism of somatostatin action on insulin release. V. Effect of somatostatin analogues on arginine induced release of insulin and glucagon from the perfused rat pancreas. Acta Endocrinol (Copenh) 1977 0.75
142 Peptidergic regulation of maturation of the stimulus-secretion coupling in fetal islet beta cells. Pancreas 2000 0.75
143 [Hormones and stress]. Nord Med 1970 0.75
144 [Somatostatin and somatomedins--new hormones with connection to diabetes research and future diabetes therapy]. Lakartidningen 1976 0.75
145 Quantitative determination of the interaction between epinephrine and various insulin releasers in man. Diabetes 1978 0.75
146 Somatostatin in the pancreas, stomach and hypothalamus of the diabetic Chinese hamster. Diabetologia 1977 0.75
147 Abnormal D cell secretion in alloxan-diabetes: influence by drug and aberrant metabolism. Am J Physiol 1984 0.75
148 Chlorpropamide and lipid metabolism of rat and human adipose tissue in vitro. Acta Med Scand 1970 0.75
149 [Diagnosis of primary aldosteronism using modern methods of study]. Srp Arh Celok Lek 1978 0.75
150 Rye products in the diabetic diet. Postprandial glucose and hormonal responses in non-insulin-dependent diabetic patients as compared to starch availability in vitro and experiments in rats. Diabetes Res Clin Pract 1987 0.75
151 Glucose tolerance, growth hormone and somatomedin levels in osteosarcoma patients. Acta Endocrinol (Copenh) 1980 0.75
152 Difference in calcium dependency of insulin, glucagon and somatostatin secretion in response to glibenclamide in perfused rat pancreas. Diabetologia 1982 0.75
153 Glucose tolerance, insulin release, and insulin sensitivity in normal-weight women with previous gestational diabetes mellitus. Diabetes 1987 0.75
154 Somatostatin in computer tomography of the abdomen. Acta Radiol Diagn (Stockh) 1979 0.75
155 Effect of somatostatin on basal and glucose induced insulin release in five patients with hyperinsulinaemia. Acta Endocrinol (Copenh) 1976 0.75
156 Release of gastrointestinal hormones into the duodenal lumen of cats. Horm Metab Res 1978 0.75
157 Release of gastrin and somatostatin into the gastric lumen of healthy subjects and patients with duodenal ulcer and achlorhydria. Acta Physiol Scand 1980 0.75
158 [Retinopathy and nephropathy in diabetes--improved diagnosis and treatment]. Lakartidningen 1988 0.75
159 [Prediabetic state, diabetes and arteriosclerosis]. Srp Arh Celok Lek 1975 0.75
160 Potentiation by previous nutrients of glibenclamide-induced insulin release in man. An effect which is counteracted by meal-induced retardation of drug absorption. Scand J Clin Lab Invest 1986 0.75
161 Capillary permeability in healthy males with different insulin response to glucose. Eur J Clin Invest 1979 0.75
162 Somatostatin. Adv Metab Disord 1978 0.75
163 Effects of fasting and refeeding on the activity of hepatic glucose-6-phosphatase in rats. Acta Physiol Scand 1985 0.75
164 Cysteamine exerts multiple effects on the endocrine cells of the rat pancreas. Biochim Biophys Acta 1985 0.75
165 Somatostatin and bleeding esophageal varices. N Engl J Med 1979 0.75
166 Extrahypophyseal effects of somatostatin. Ann Clin Res 1978 0.75
167 Previous exposure to glucose enhances insulin and suppresses glucagon responses to arginine in man. Acta Diabetol Lat 1981 0.75
168 Intravenous glucose tolerance, insulin response to glucose, peripheral sensitivity to insulin, and serum lipoproteins in post-myocardial infarct patients with normal fasting blood glucose. Horm Metab Res 1984 0.75
169 Somatostatin, more than a third pancreatic hormone. Rev Invest Clin 1976 0.75
170 [Treatment of severe diabetic ketosis with or without coma]. Lakartidningen 1975 0.75
171 An endogenous peptide isolated from the gut, NK-lysin, stimulates insulin secretion without changes in cytosolic free Ca2+ concentration. FEBS Lett 1998 0.75